Source: Annual Congress 2010 - Pulmonary circulation: clinical aspects
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Hurdman, R. Condliffe, C. A. Elliot, C. Davies, C. Hill, D. Capener, J. Wild, I. Armstrong, N. Hamilton, P. Sephton, I. Sabroe, D. G. Kiely (Sheffield, United Kingdom). Clinical classification of pulmonary hypertension(PH) and implications for survival. Eur Respir J 2010; 36: Suppl. 54, 5603

Member's Comments

No comment yet.

Related content which might interest you: Clinical prognostic tools and their use in COPD. Source: Virtual Congress 2020 – Clinical and functional evaluation of COPD Year: 2020 Clinical features and outcome of pulmonary carcinoid - a 16 years review Source: Eur Respir J 2002; 20: Suppl. 38, 77s Year: 2002 Physiological predictors of survival in patients with sarcoidosis-associated pulmonary hypertension: results from an international registry Source: Eur Respir J, 55 (5) 1901747; 10.1183/13993003.01747-2019 Year: 2020 Surrogate markers of right ventricular adaptation better predict long-term survival in patients with PAH than traditional prognostic variables Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment Year: 2013 Clinical profile and outcome of complicated pulmonary tuberculosis in children Source: Eur Respir J 2002; 20: Suppl. 38, 362s Year: 2002 Pulmonary hypertension and lung diseases: a suggestion for revision of the clinical classification Source: Eur Respir J 2010; 35: 700-701 Year: 2010 Correlation of nutritional status using subjective global assessment (SGA) on pulmonary function parameters in patients with COPD at the Philippine Heart Center Source: Annual Congress 2013 –Disease control and quality of life in airway diseases Year: 2013 Clinical and functional staging of COPD Source: Annual Congress 2004 - Diagnosis and staging of COPD Year: 2004 Idiopathic pulmonary fibrosis: Clinical, radiological and functional significance of biomarkers of proliferation Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease Year: 2012 Clinical features and short-term outcomes of cancer patients with suspected and unsuspected pulmonary embolism: the EPIPHANY study Source: Eur Respir J 2017; 49(1): 1600282; DOI: 10.1183/13993003.00282-2016 Year: 2017 Clinical implications Source: Annual Congress 2007 - Pulmonary biomarkers in COPD Year: 2007 Clinical implications of the new concepts regarding COPD pathophysiology Source: Annual Congress 2008 - New insights into COPD pathophysiology Year: 2008 Clinical characteristics and treatment outcomes of patients with pulmonary tuberculosis with delayed conversion over 4 months Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015 Pulmonary arterial hypertension-related morbidity is prognostic for survival: insights from the SERAPHIN and GRIPHON studies Source: International Congress 2017 – New insights into pulmonary hypertension from recent trials Year: 2017 Mortality and classification of airway obstruction severity by different methods Source: International Congress 2016 – Quality and quantity in lung function Year: 2016 Clinical characteristics and prognosis of chronic pulmonary aspergillosis Source: International Congress 2019 – Clinical challenges in respiratory infection Year: 2019 Paediatric pulmonary arterial hypertension: updates on definition, classification, diagnostics and management Source: Eur Respir J, 53 (1) 1801916; 10.1183/13993003.01916-2018 Year: 2019 Different definitions of pulmonary hypertension in interstitial lung disease: a prognostic evaluation. Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020